世界卫生组织（WHO）：2025呼吸道合胞病毒儿科药物优化会议报告（英文版）（32页）.pdf

1、Paediatric drug optimization for respiratory syncytial virus Meeting report,April 2025Paediatric drug optimization for respiratory syncytial virus Meeting report,April 2025 World Health Organization 2025Some rights reserved.This work is available under the Creative Commons Attribution-NonCommercial-

2、ShareAlike 3.0 IGO licence(CC BY-NC-SA 3.0 IGO;https:/creativecommons.org/licenses/by-nc-sa/3.0/igo).Under the terms of this licence,you may copy,redistribute and adapt the work for non-commercial purposes,provided the work is appropriately cited,as indicated below.In any use of this work,there shou

3、ld be no suggestion that WHO endorses any specific organization,products or services.The use of the WHO logo is not permitted.If you adapt the work,then you must license your work under the same or equivalent Creative Commons licence.If you create a translation of this work,you should add the follow

4、ing disclaimer along with the suggested citation:“This translation was not created by the World Health Organization(WHO).WHO is not responsible for the content or accuracy of this translation.The original English edition shall be the binding and authentic edition”.Any mediation relating to disputes

5、arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization (http:/www.wipo.int/amc/en/mediation/rules/).Suggested citation.Paediatric drug optimization for respiratory syncytial virus:meeting report,April 2025.Geneva:World Heal

6、th Organization;2025.https:/doi.org/10.2471/B09464.Licence:CC BY-NC-SA 3.0 IGO.Cataloguing-in-Publication(CIP)data.CIP data are available at https:/iris.who.int/.Sales,rights and licensing.To purchase WHO publications,see https:/www.who.int/publications/book-orders.To submit requests for commercial